Yubi Lin

<scp>SGLT2</scp> inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the <scp>HIF</scp> ‐2α signaling pathway in arrhythmogenic cardiomyopathy

Zhe Yang, Tengling Li, Jianzhong Xian et al. · The FASEB Journal · 2022 · 69 citations · Full text

Young and early‐onset dilated cardiomyopathy with malignant ventricular arrhythmia and sudden cardiac death induced by the heterozygous LDB3, MYH6, and SYNE1 missense mutations

Ting Zhao, Yuting Ma, Z. Zhang et al. · Annals of Noninvasive Electrocardiology · 2021 · 34 citations · Full text

Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy

Qian-Jie Tang, Heping Lei, Jiyan Chen et al. · Acta Pharmacologica Sinica · 2018 · 33 citations · Full text

Thrombosis, Hypertension, Dual Antiplatelet Therapy +11

Effect of Epicardial Fat Pad Ablation on Acute Atrial Electrical Remodeling and Inducibility of Atrial Fibrillation

Chang Dong, Shulong Zhang, Donghui Yang et al. · Circulation Journal · 2010 · 28 citations · Full text

Rare and potential pathogenic mutations of LMNA and LAMA4 associated with familial arrhythmogenic right ventricular cardiomyopathy/dysplasia with right ventricular heart failure, cerebral thromboembolism and hereditary electrocardiogram abnormality

Jia Chen, Yuting Ma, Hong Li et al. · Orphanet Journal of Rare Diseases · 2022 · 27 citations · Full text